Tourmaline Bio Correlations
TRML Stock | 25.00 0.36 1.42% |
The current 90-days correlation between Tourmaline Bio and Valneva SE ADR is 0.18 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tourmaline Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tourmaline Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Tourmaline Bio Correlation With Market
Modest diversification
The correlation between Tourmaline Bio and DJI is 0.22 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tourmaline Bio and DJI in the same portfolio, assuming nothing else is changed.
Tourmaline |
Moving together with Tourmaline Stock
0.66 | FLGC | Flora Growth Corp | PairCorr |
0.66 | GNFT | Genfit | PairCorr |
0.65 | LPCN | Lipocine | PairCorr |
0.76 | ALVO | Alvotech | PairCorr |
Moving against Tourmaline Stock
0.57 | PTN | Palatin Technologies | PairCorr |
0.44 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.34 | ERNA | Eterna Therapeutics | PairCorr |
0.43 | INKT | Mink Therapeutics | PairCorr |
0.41 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.34 | AKAN | Akanda Corp | PairCorr |
0.33 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
0.75 | TOVX | Theriva Biologics | PairCorr |
0.49 | TTOO | T2 Biosystms | PairCorr |
0.48 | SMMT | Summit Therapeutics PLC | PairCorr |
0.46 | TELO | Telomir Pharmaceuticals, | PairCorr |
0.32 | ANRO | Alto Neuroscience, | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Tourmaline Stock performing well and Tourmaline Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tourmaline Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EQ | 4.25 | (0.27) | 0.00 | (0.03) | 0.00 | 13.33 | 64.12 | |||
DMAC | 2.60 | 0.36 | 0.11 | 1.73 | 2.24 | 6.41 | 18.09 | |||
VALN | 2.22 | (0.70) | 0.00 | 6.44 | 0.00 | 3.61 | 12.07 | |||
VANI | 2.27 | 0.05 | 0.01 | 0.17 | 2.54 | 5.36 | 20.23 | |||
DNLI | 2.48 | (0.32) | 0.00 | 0.00 | 0.00 | 6.73 | 22.00 | |||
DNTH | 2.86 | (0.24) | 0.00 | (0.10) | 0.00 | 7.13 | 16.65 | |||
DOMH | 2.53 | (0.31) | 0.00 | (0.18) | 0.00 | 6.41 | 23.01 | |||
VCEL | 2.12 | 0.24 | 0.15 | 0.25 | 1.98 | 5.15 | 12.86 | |||
VCNX | 6.47 | (0.05) | (0.01) | 0.00 | 11.01 | 11.52 | 54.95 | |||
VCYT | 2.08 | 0.48 | 0.19 | 0.51 | 2.05 | 5.42 | 14.52 |
Tourmaline Bio Corporate Management
Susan Jones | Chief Officer | Profile | |
Kimberly Piorkowski | Culture People | Profile | |
Bradford JD | General Officer | Profile | |
Dr MBA | Chief Officer | Profile | |
Emil MD | Senior Research | Profile | |
Yung MD | Chief Officer | Profile |